Spots Global Cancer Trial Database for Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
Official Title: An Open-Label, Multi-Centre, Randomised Parallel-Group Dose-Finding Study, Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
Study ID: NCT00468286
Conditions
Study Description
Brief Summary: The study will have two treatment groups, evaluating two Degarelix doses. First dose is the initial dose followed by a maintenance dose given every three months. The initial dose given to suppress the testosterone level and the three month maintenance dose to maintain the suppressed testosterone level over one year of treatment.
Detailed Description: An Open-Label, Multi-Centre, Randomized Parallel-Group Dose-Finding Study, Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients with Prostrate Cancer Requiring Androgen Ablation Therapy.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Urology Centers of Alabama, Homewood, Alabama, United States
South Orange County Medical Research Center, Laguna Woods, California, United States
South Florida Medical Research, Aventura, Florida, United States
Florida Foundation for Healthcare Research, Ocala, Florida, United States
Regional Urology, Shreveport, Louisiana, United States
Investigational site, Carmel, New York, United States
The Urology Center, Greensboro, North Carolina, United States
State College Urologic Association, State College, Pennsylvania, United States
Grand Strand Urology, Myrtle Beach, South Carolina, United States
Urology of Virginia Research, Norfolk, Virginia, United States
Urology Research Center, Seattle, Washington, United States
Investigational site, Surrey, British Columbia, Canada
Investigational site, Victoria, British Columbia, Canada
Investigational site, Kentville, Nova Scotia, Canada
The Female/Male Health Centres, Ontario, , Canada
Nemocnice Jindrichuv Hradec a.s., Hradec, , Czech Republic
Slezska nemocnice, Opava, , Czech Republic
Vseobecna fakultni nemocnice v Praze, Praha, , Czech Republic
Dombóvári Szent Lukács Egészségügyi Kht, Dombovar, , Hungary
Borsod-Abaúj-Zemplé n Megyei Kórház és Egyetemi Oktató Kórház, Miskolc, , Hungary
Miskolc Megyei Jogú Város Önkormányzat Miskolci Egészségügyi Központ, Miskolc, , Hungary
Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ, Szeged, , Hungary
Private Medical Center, Arad, , Romania
"Prof Dr Th Burghele" Clinical Hospital, Bucharest, , Romania
Dinu Uromedica, Bucharest, , Romania
Fundeni Clinical Institute, Bucharest, , Romania
E-Uro Medical Center S.R.L., Cluj-Napoca, , Romania
Provita Center, Constanta, , Romania
Sibiu County Clinical Hospital, Sibiu, , Romania
Contact Details
Name: Clinical Development Support
Affiliation: Ferring Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
